Shuttle Pharmaceuticals Holdings (SHPH) Non-Current Debt (2021 - 2023)

Shuttle Pharmaceuticals Holdings' Non-Current Debt history runs 3 years deep, the most recent figure standing at $139229.0 for Q1 2023.

• On a quarterly basis, Non-Current Debt changed N/A year-over-year to $139229.0 in Q1 2023; TTM through Mar 2023 was $139229.0, a N/A change from a year earlier, with the FY2022 full-year figure at $73007.0, changed 0.0% from the prior year.
• Non-Current Debt grew to $139229.0 in Q1 2023 per SHPH's latest filing, from $73007.0 in the prior quarter.
• Across five years, Non-Current Debt topped out at $139229.0 in Q1 2023 and bottomed at $73007.0 in Q4 2021.
• The 3-year median for Non-Current Debt is $73007.0 (2021), against an average of $89562.5.
• Biggest YoY gain for Non-Current Debt was 0.0% in 2022; the steepest drop was 0.0% in 2022.
• Year by year, Non-Current Debt stood at $73007.0 in 2021, then changed by 0.0% to $73007.0 in 2022, then soared by 90.71% to $139229.0 in 2023.
• Per Business Quant, the three latest SHPH Non-Current Debt figures stand at $139229.0 (Q1 2023), $73007.0 (Q4 2022), and $73007.0 (Q3 2022).